Boston Trust Walden Corp Eli Lilly & CO Transaction History

Boston Trust Walden Corp

$13.3 Billion
Q2 2024

A detailed history of Boston Trust Walden Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Boston Trust Walden Corp holds 3,333 shares of LLY stock, worth $3.03 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,333

Previous 3,441 3.14%

Holding current value

$3.03 Million

Previous $2.68 Million 12.74%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $78,285 - $98,176	-108 Reduced 3.14%	3,333 $3.02 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $109,557 - $146,571	-185 Reduced 5.1%	3,441 $2.68 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $68,274 - $80,486	130 Added 3.72%	3,626 $2.11 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $65,205 - $89,895	-150 Reduced 4.11%	3,496 $1.88 Million
Q2 2023 Jul 24, 2023	BUY	$350.74 - $468.98 $140,997 - $188,529	402 Added 12.39%	3,646 $1.71 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $27,956 - $32,833	-90 Reduced 2.7%	3,244 $1.11 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $291,551 - $342,324	1,046 Added 45.72%	3,334 $1.08 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $476,420 - $592,069	-2,030 Reduced 47.01%	2,288 $655,000
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 2.26%	4,318 $807,000
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $14,089 - $18,644	108 Added 2.51%	4,418 $746,000
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $14,475 - $16,743	-99 Reduced 2.25%	4,310 $638,000
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $102,314 - $123,135	-750 Reduced 14.54%	4,409 $724,000
Q1 2020 Apr 21, 2020	SELL	$119.05 - $147.35 $10,714 - $13,261	-90 Reduced 1.71%	5,159 $716,000
Q4 2019 Jan 10, 2020	SELL	$106.92 - $132.43 $17,214 - $21,321	-161 Reduced 2.98%	5,249 $690,000
Q3 2019 Oct 21, 2019	SELL	$106.79 - $116.16 $21,358 - $23,232	-200 Reduced 3.57%	5,410 $605,000
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $3,323 - $3,879	30 Added 0.54%	5,610 $622,000
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $5,565 - $6,551	-50 Reduced 0.89%	5,580 $724,000
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $124,677 - $143,091	-1,647 Reduced 22.63%	5,630 $480,000
Q1 2018 Apr 13, 2018	SELL	$74.21 - $87.6 $29,683 - $35,040	-400 Reduced 5.21%	7,277 $563,000
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $21,304 - $22,851	-260 Reduced 3.28%	7,677 $648,000
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $611,704 - $678,930	7,937	7,937 $679,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Eli Lilly & CO Transaction History